Neoadjuvant Chemotherapy for Resectable Cancer of the Pancreatic Head
NCT00490360
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
2007
Enrollment
OTHER
Sponsor class
Conditions
Cancer of the Pancreatic Head
Interventions
DRUG:
Gemcitabine / Cisplatin
Sponsor
University of Zurich